ARTICLE | Company News
Oxford BioDynamics partners EpiSwitch platform
November 16, 2018 6:01 PM UTC
Oxford BioDynamics plc (LSE:OBD) said it partnered with an undisclosed major U.S. pharma to use its EpiSwitch epigenetic biomarker platform to develop predictive biomarkers for immuno-oncology therape...
BCIQ Company Profiles